SCHADE CHRISTIAN S 4

4 · Aprea Therapeutics, Inc. · Filed Aug 1, 2022

Form 4

Period: 2022-07-28

DirectorPresident & CEO

Transactions

Award
Stock Option (right to Buy)
2022-07-28+47,600→ 47,600 total
Exercise: $1.09Exp: 2032-07-28→ Common Stock (47,600 underlying)
Award
Common Stock
2022-07-28+32,400→ 259,246 total

Holdings

Footnotes (3)

[F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
[F2]The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
[F3]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.

Documents

1 file